LASA SUPERGENERICS
|
The Current P/S Ratio of LASA SUPERGENERICS is 1.10.
Share Price | ₹26.3 | Jan 22,2025 |
Market Cap | ₹131.6 Cr | |
Sales-TTM | ₹119.7 Cr | TTM-Standalone Results |
Price/Sales | 1.10x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of LASA SUPERGENERICS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹131.6 Cr] as on Jan 22,2025
(/) Sales [ ₹119.7 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 1.10x ]
Thus, for LASA SUPERGENERICS , the investors are currently willing to pay '1.10 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of LASA SUPERGENERICS !
The chart below summarizes the trend in P/S Ratio of LASA SUPERGENERICS over the last five years.
Historical PS (Price/Sales) ratio chart of LASA SUPERGENERICS
PS Ratio Performance Analysis for LASA SUPERGENERICS
- LASA SUPERGENERICS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.03x.
- LASA SUPERGENERICS 's operated at median p/e ratio of 1.05x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LASA SUPERGENERICS 's p/e ratio peaked in Mar2022 at 1.52x.
- LASA SUPERGENERICS 's p/e ratio hit its five-year low in Mar2020 of 0.69x.
How does LASA SUPERGENERICS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
LASA SUPERGENERICS | 119.7 | 1.10 | 131.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.58 | 431,400.0 |
CIPLA LTD | 26,512.0 | 4.38 | 116,240.0 |
DR REDDYS LABORATORIES LTD | 30,084.9 | 3.60 | 108,166.0 |
ZYDUS LIFESCIENCES LTD | 21,483.5 | 4.58 | 98,495.2 |
DIVIS LABORATORIES LTD | 8,614.0 | 17.95 | 154,622.0 |
MANKIND PHARMA LTD | 11,018.0 | 9.42 | 103,763.0 |
TORRENT PHARMACEUTICALS LTD | 11,225.0 | 9.55 | 107,179.0 |
LUPIN LTD | 21,431.3 | 4.55 | 97,570.3 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.28 | 69,185.1 |
ABBOTT INDIA LTD | 6,066.1 | 9.72 | 58,958.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs LASA SUPERGENERICS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.10x |
Max industry PS | 17.95x |
Median industry PS | 4.58x |
Average industry PS | 6.88x |
You may also like the below Video Courses